Avantor, Inc. (NYSE:AVTR) Q2 2022 Earnings Conference Call July 29, 2022 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President, Chief Executive Officer & Director Thomas Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore Dan Brennan - Cowen Luke Sergott - Barclays Rachel Vatnsdal - JPMorgan Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Paul Knight - KeyBanc Jack Meehan - ...

Avantor, Inc. (NYSE:AVTR) Q1 2022 Results Conference Call April 29, 2022 7:30 AM ET Company Participants Tommy Thomas - Vice President, Investor Relations Michael Stubblefield - President and CEO Tom Szlosek - Executive Vice President and CFO Conference Call Participants Derik De Bruin - Bank of America Vijay Kumar - Evercore Dan Brennan - Cowen Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Paul Knight - KeyBanc Capital Markets Operator Good ...

Avantor, Inc. (NYSE:AVTR) Q4 2021 Earnings Conference Call February 4, 2022 7:30 AM ET Company Participants Tommy Thomas - Vice President, Investor Relations Michael Stubblefield - President and CEO Tom Szlosek - Executive Vice President and CFO Conference Call Participants Derik de Bruin - Bank of America Vijay Kumar - Evercore ISI Dan Brennan - Cowen Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Patrick Donnelly - Citi Matt Sykes - Goldman Sachs Dan Leonard - Wells Fargo Operator Good morni ...

Financial Performance - Fourth quarter organic revenue grew by 2.5%, driven by Biopharma and ATAM, with core growth at approximately 4.6% and COVID-19 headwinds of approximately 2.1%[8] - Fourth quarter adjusted EBITDA increased by 15.6%, reflecting mix, inflation management, and productivity, with over 150 bps margin expansion, including approximately 90 bps from M&A[8] - Fourth quarter adjusted EPS grew by 21.4%, driven by execution and benefits from interest and tax initiatives[8] - Full-year 2021 organic revenue growth reached 11.3%, exceeding initial guidance of 4-7%[9] - Full-year 2021 adjusted EPS growth was 57.7%, surpassing initial guidance of approximately 30%[9] - Full-year 2021 free cash flow was $920 million, exceeding initial guidance of approximately $800 million[9] Strategic Initiatives and Outlook - The company closed the acquisition of Masterflex, expanding its single-use offering for bioproduction workflows[7] - The company launched LC/MS consumables from Agilent Technologies to enhance workflow solutions[7] - Initial 2022 guidance includes organic revenue growth of 4-6% and reported growth of 7-9%[23] - The company anticipates adjusted EBITDA margin expansion of over 125 bps in 2022, approaching 21%[23] - The company projects 2022 adjusted EPS to be in the range of $1.45-$1.53, representing a reported growth of 10-16%[23]

Avantor, Inc. (NYSE:AVTR) Q3 2021 Earnings Conference Call October 29, 2021 7:30 AM ET Company Participants Tommy Thomas - Vice President-Investor Relations Michael Stubblefield - President & Chief Executive Officer Tom Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - JPMorgan Derik de Bruin - Bank of America Vijay Kumar - Evercore ISI Dan Brennan - Cowen Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Patrick Donnelly - Citi Catherine S ...